Agilent Technologies, Inc. (A) Financials

A Assets vs Liabilities

DateAssetsLiabilities
2024-01-31 10.9 billion 4.8 billion
2023-10-31 10.8 billion 4.9 billion
2023-07-31 10.7 billion 5.1 billion
2023-04-30 10.8 billion 5.0 billion

A Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-01-31 485.0 million 44.0 million
2023-10-31 432.0 million 14.0 million
2023-07-31 481.0 million 29.0 million
2023-04-30 341.0 million 24.0 million

A Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2024-01-31 348.0 million
2023-10-31 475.0 million
2023-07-31 111.0 million
2023-04-30 302.0 million

A Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-01-31 1.7 billion - -
2023-10-31 1.6 billion - -
2023-07-31 1.3 billion 2.7 billion -
2023-04-30 1.2 billion 2.7 billion -

A Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-01-31 294.0 million
2023-10-31 293.0 million
2023-07-31 295.0 million
2023-04-30 297.0 million

A Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-01-31 - 128.0 million - -
2023-10-31 84.0 million 114.0 million 393.0 million -
2023-07-31 81.0 million 118.0 million 407.0 million -
2023-04-30 57.0 million 126.0 million 415.0 million -

A Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-01-31 1.7 billion 750.0 million
2023-10-31 1.7 billion 773.0 million
2023-07-31 1.7 billion 1.0 billion
2023-04-30 1.7 billion 793.0 million

A

List: Contenders

Price: $137.52

52 week price:
96.80
151.58

Dividend Yield: 0.01%

5-year range yield:
0.01%
0.99%

Forward Dividend Yield: 0.69%

Payout Ratio: 22.53%

Payout Ratio Range:
9.10%
67.63%

Dividend Per Share: 0.94 USD

Earnings Per Share: 4.18 USD

P/E Ratio: 31.74

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 1.7 million

Ebitda: 304.0 million

Market Capitalization: 42.2 billion

Average Dividend Frequency: 4

Years Paying Dividends: 13

DGR3: 7.17%

DGR5: 7.91%

DGR10: 9.16%

Links: